Home › Funds › PERCEPTIVE ADVISORS LLC › TVTX
PERCEPTIVE ADVISORS LLC position in TVTX
TRAVERE THERAPEUTICS INC · Health Care
PERCEPTIVE ADVISORS LLC reported holding 3,752,574 shares of TVTX (TRAVERE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$213.2M, representing 3.38% of its reported portfolio and ranking #7 among its reported holdings. PERCEPTIVE ADVISORS LLC has disclosed TVTX holdings in 7 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How PERCEPTIVE ADVISORS LLC's TVTX position evolved
PERCEPTIVE ADVISORS LLC first disclosed a stake in TVTX in Q3 2023 at 400,000 shares (US$3.6M). The position peaked in Q2 2026 at 3,752,574 shares, worth US$213.2M. Across 7 filings, PERCEPTIVE ADVISORS LLC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 3,752,574 shares valued at US$213.2M — a reduction of -389,977 shares quarter over quarter.. Notable position changes include a 355% increase in Q3 2025 (shares rose 60% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 400.00K | $3.58M | New |
| Q4 2023 | 400.00K | $3.60M | Hold |
| Q2 2025 | 834.25K | $12.35M | New |
| Q3 2025 | 3.79M | $90.69M | Add |
| Q4 2025 | 4.28M | $163.47M | Add |
| Q1 2026 | 4.14M | $123.08M | Reduce |
| Q2 2026 | 3.75M | $213.18M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TVTX and 13F data
TVTX (TRAVERE THERAPEUTICS INC) is a Health Care company. 56 other funds we track also report a position in TVTX — the largest reported positions include Rock Springs Capital Management LP (US$123.8M), Kynam Capital Management, LP (US$113.6M), Stephens Investment Management Group LLC (US$106.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TVTX
- Rock Springs Capital Management LP 2.18M sh · $123.79M · Q2 2026
- Kynam Capital Management, LP 2.00M sh · $113.62M · Q2 2026
- Stephens Investment Management Group LLC 1.88M sh · $106.54M · Q2 2026
- EMERALD ADVISERS, LLC 1.60M sh · $90.95M · Q2 2026
- MPM BioImpact LLC 1.12M sh · $63.78M · Q2 2026
- Context Capital Management, LLC 50.50M sh · $59.46M · Q2 2026
- EMERALD MUTUAL FUND ADVISERS TRUST 1.03M sh · $58.63M · Q2 2026
- Eversept Partners, LP 798.97K sh · $45.39M · Q2 2026
- Polar Asset Management Partners Inc. 30.50M sh · $35.91M · Q2 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 28.00M sh · $32.96M · Q2 2026
- ARMISTICE CAPITAL, LLC 500.00K sh · $28.41M · Q2 2026
- Graham Capital Management, L.P. 446.70K sh · $25.38M · Q2 2026
More on PERCEPTIVE ADVISORS LLC
FAQ
How long has PERCEPTIVE ADVISORS LLC held TVTX?
PERCEPTIVE ADVISORS LLC has disclosed TVTX holdings in 7 of the last 12 reported quarters, going back to Q3 2023.
What is PERCEPTIVE ADVISORS LLC's current position in TVTX?
As of Q2 2026, PERCEPTIVE ADVISORS LLC holds 3.75M shares of TVTX (TRAVERE THERAPEUTICS INC), valued at $213.18M, representing 3.38% of its reported portfolio and ranking #7.
Has PERCEPTIVE ADVISORS LLC been buying or selling TVTX?
In the latest 13F filing (Q2 2026), PERCEPTIVE ADVISORS LLC reduced its position in TVTX. The position peaked in Q2 2026 at 3.75M shares.
Which other funds hold TVTX?
Other major institutional holders of TVTX include Rock Springs Capital Management LP, Kynam Capital Management, LP, Stephens Investment Management Group LLC, among 56 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.